Informed-money record

CRNX · Crinetics Pharmaceuticals, Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

Bearish filings

Named actors

Disclosed $ (bull / bear)

$1.2M / $19.9M + 5 of unknown size

Recent disclosures

25 of 47 in the window · linked to source

Date	Who	What	Disclosed $	Receipt
2026-08-07	President & CEO Struthers Richard Scott	exercised options & held the shares	$502K	SEC ↗
2026-07-30	Congress Gilbert Cisneros	sold	$33K	—
2026-07-02	Director Vivaldi Coelho Rogerio	sold	$120K	SEC ↗
2026-07-02	Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) ROGERIO VIVALDI COELHO	filed notice to sell	$232K	SEC ↗
2026-07-02	Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JEFF KNIGHT	filed notice to sell	$1.8M	SEC ↗

22 more disclosures in the window — the full record, scoring, and track-record evidence are for members.

Want the read, not just the record?

Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.

Start free — 1 week, no card →

Dispute or correct this record

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals